SB

Serge Belanger Needham Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
CYTK icon
1
Cytokinetics
CYTK
$5.95B
$49.75 $72
45%
upside
Buy 2 days ago
OCS icon
2
Oculis Holding
OCS
$898M
$17.16 $36
110%
upside
Buy 8 days ago
AMPH icon
3
Amphastar Pharmaceuticals
AMPH
$1.36B
$29.19 $36
23%
upside
Buy 23 days ago
LQDA icon
4
Liquidia Corp
LQDA
$2.48B
$28.84 $36
25%
upside
Buy 23 days ago
TRVI icon
5
Trevi Therapeutics
TRVI
$880M
$7.23 $22
204%
upside
Buy 27 days ago
ARQT icon
6
Arcutis Biotherapeutics
ARQT
$1.94B
$16.21 $22
36%
upside
Buy 28 days ago
VRDN icon
7
Viridian Therapeutics
VRDN
$1.52B
$18.64 $34
82%
upside
Buy 29 days ago
EOLS icon
8
Evolus
EOLS
$486M
$7.51 $22
193%
upside
Hold 29 days ago
OCUL icon
9
Ocular Therapeutix
OCUL
$2.21B
$12.70 $15
18%
upside
Buy 1 month ago
BCRX icon
10
BioCryst Pharmaceuticals
BCRX
$1.74B
$8.27 $17
106%
upside
Buy 1 month ago
CRMD icon
11
CorMedix
CRMD
$956M
$12.80 $20
56%
upside
Buy 2 months ago
NAMS icon
12
NewAmsterdam Pharma
NAMS
$2.89B
$25.66 $40
56%
upside
Buy 2 months ago
MLTX icon
13
MoonLake Immunotherapeutics
MLTX
$3.79B
$59.72 $66
11%
upside
Buy 3 months ago
XENE icon
14
Xenon Pharmaceuticals
XENE
$2.98B
$38.64 $55
42%
upside
Buy 3 months ago
PCRX icon
15
Pacira BioSciences
PCRX
$1.2B
$26.73 $30
12%
upside
Buy 3 months ago
ESPR icon
16
Esperion Therapeutics
ESPR
$510M
$2.53 $4
58%
upside
Buy 4 months ago
COLL icon
17
Collegium Pharmaceutical
COLL
$1.24B
$39.23 $46
17%
upside
Buy 4 months ago
KALV icon
18
KalVista Pharmaceuticals
KALV
$765M
$15.20 $28
84%
upside
Buy 4 months ago
ARQT icon
19
Arcutis Biotherapeutics
ARQT
$1.94B
$16.21 $8
51%
downside
Buy 1 year ago